Bialoom

Description

Bialoom develops silicon plasmo-photonic biosensor biochips embedded in disposable cartridges, quantifying biomarker signatures from patient blood to support faster, evidence-based diagnosis and treatment of severe infections.

Related

• AntabioAntabio develops antibacterial therapies for multidrug-resistant Gram-negative infections and advances Meropenem-Pilabactam, a…
• CamurusCamurus develops and commercializes long-acting pharmaceutical medicines using its proprietary FluidCrystal technology for treatment of…
• ASMLASML develops lithography systems that enable leading chipmakers to mass-produce microchip patterns on silicon, making chips smaller,…
• CARTHERACARTHERA develops SonoCloud, an implanted ultrasound device that emits low-intensity pulsed ultrasound to transiently open the blood–brain…
• QT SenseQT Sense (Quantum Nuova) provides a quantum biosensing platform using fluorescent nanodiamonds and advanced optics, data analytics, and…
• UpFront DiagnosticsUpFront Diagnostics develops a portable rapid blood test that detects stroke biomarkers GFAP and others, delivering clinically validated…
• Quantum BiometronicsQuantum Biometronics develops quantum-bio products, including laser pupillometry for nervous-system diagnosis, quantum-based biometric…
• scanvioscanvio provides Scanvio Assist™, an AI-guided ultrasound software that gives real-time, AI-assisted image assessment and live feedback to…
• Anacalypsis TherapeuticsAnacalypsis Therapeutics creates precision gene- and pathway-based therapeutic strategies, biomarkers, and genetically linked targets to…